Growth Metrics

Eli Lilly (LLY) Gross Profit (2016 - 2024)

Eli Lilly's Gross Profit history spans 17 years, with the latest figure at $15.9 billion for Q4 2025.

  • For Q4 2025, Gross Profit rose 43.04% year-over-year to $15.9 billion; the TTM value through Dec 2025 reached $54.1 billion, up 47.79%, while the annual FY2025 figure was $54.1 billion, 47.79% up from the prior year.
  • Gross Profit reached $15.9 billion in Q4 2025 per LLY's latest filing, up from $14.6 billion in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $15.9 billion in Q4 2025 to a low of $4.8 billion in Q2 2021.
  • Average Gross Profit over 5 years is $8.0 billion, with a median of $6.8 billion recorded in 2023.
  • Peak YoY movement for Gross Profit: decreased 7.05% in 2023, then skyrocketed 57.45% in 2025.
  • A 5-year view of Gross Profit shows it stood at $5.9 billion in 2021, then dropped by 3.29% to $5.8 billion in 2022, then surged by 31.49% to $7.6 billion in 2023, then skyrocketed by 47.11% to $11.1 billion in 2024, then skyrocketed by 43.04% to $15.9 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Gross Profit are $15.9 billion (Q4 2025), $14.6 billion (Q3 2025), and $13.1 billion (Q2 2025).